Usefulness of seasonal malaria chemoprevention in the Sahel

Kayiba Kalenda, Nadine;Tshibangu-Kabamba, Evariste;Nakagama, Yu;Kaku, Natsuko;Kido, Yasutoshi;et.al.
(2023) The Lancet Infectious Diseases — Vol. 23, n° 3, p. 269-270 (2023)

Files

SpeybroeckUsefulness.pdf
  • Open Access
  • Adobe PDF
  • 107.98 KB
Download

Details

Authors
  • Kayiba Kalenda, NadineUCLouvain
    Author
  • Tshibangu-Kabamba, Evariste
    Author
  • Nakagama, Yu
    Author
  • Kaku, Natsuko
    Author
  • Speybroeck, NikoUCLouvain
    Author
  • Kido, Yasutoshi
    Author
Show more
Abstract
(en) Seasonal malaria chemoprevention is an important intervention recommended for children aged 3–59 months living in highly seasonal transmission areas of the Sahel subregion of Africa to provide protection against malaria during the rainy season. In The Lancet Infectious Diseases, Colin J Sutherland and colleagues report on the prevalence of Plasmodium falciparum genetic variants associated with drug resistance before and after the implementation of seasonal malaria chemoprevention with sulfadoxine–pyrimethamine plus amodiaquine in areas across seven Sahelian countries (Burkina Faso, Chad, Guinea, Mali, Nigeria, Niger, and The Gambia). [...]
Affiliations

Citations

  • APA
  • Chicago
  • FWB

Kayiba Kalenda, N., Tshibangu-Kabamba, E., Nakagama, Y., Kaku, N., Kaneko, A., Speybroeck, N., & Kido, Y. (2023). Usefulness of seasonal malaria chemoprevention in the Sahel. The Lancet Infectious Diseases, 23(3), 269-270. https://doi.org/10.1016/s1473-3099(22)00654-5 (Original work published 2023)